The bradykinin/B1 receptor promotes angiogenesis by up‐regulation of endogenous FGF‐2 in endothelium via the nitric oxide synthase pathway
- 27 April 2001
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 15 (8) , 1487-1489
- https://doi.org/10.1096/fj.00-0503fje
Abstract
No abstract availableFunding Information
- Associazione Italiana per la Ricerca sul Cancro
This publication has 35 references indexed in Scilit:
- B1 receptors as a new inflammatory target. Could this B the 1?Trends in Pharmacological Sciences, 1999
- B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF‐2 effectsBritish Journal of Pharmacology, 1998
- Role of kinins in the endothelial protective effect of ischaemic preconditioningBritish Journal of Pharmacology, 1998
- Regulation of mitogenesis by kinins in arterial smooth muscle cellsAmerican Journal of Physiology-Cell Physiology, 1997
- Wound Healing following Myocardial Infarction in the Rat: Role for Bradykinin and ProstaglandinsJournal of Molecular and Cellular Cardiology, 1996
- Nitric oxide pathway‐mediated relaxant effect of bradykinin in the guinea‐pig isolated tracheaBritish Journal of Pharmacology, 1994
- Bradykinin receptor types and B2 subtypesLife Sciences, 1994
- [Leu8]des-Arg9-bradykinin inhibits the angiogenic effect of bradykinin and interleukin-1 in ratsBritish Journal of Pharmacology, 1993
- Bradykinin receptors: Pharmacological properties and biological rolesPharmacology & Therapeutics, 1992
- Kinins act on B1 or B2 receptors to release conjointly endothelium‐derived relaxing factor and prostacyclin from bovine aortic endothelial cellsBritish Journal of Pharmacology, 1989